T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Domo
DOMO
$184M
| $232K | ﹤0.01% |
75,616
+23,506
| +45% | +$119K |
|
2777
Vitamin Cottage Natural Grocers
NGVC
$635M
| $232K | ﹤0.01% |
+8,973
| New | +$232K |
|
2778
Savers
SVV
$1.81B
| $232K | ﹤0.01% |
31,109
+7,240
| +30% | +$69.2K |
|
2779
Tencent Music
TME
$14.3B
| $232K | ﹤0.01% |
24,903
| – | – |
|
2780
Arcturus Therapeutics
ARCT
$214M
| $231K | ﹤0.01% |
29,793
+3,679
| +14% | +$26.8K |
|
2781
Farmers & Merchants Bancorp
FMAO
$483M
| $230K | ﹤0.01% |
+8,942
| New | +$233K |
|
2782
Cerus
CERS
$516M
| $229K | ﹤0.01% |
125,442
+14,394
| +13% | +$31.4K |
|
2783
RBB Bancorp
RBB
$458M
| $229K | ﹤0.01% |
10,682
| – | – |
|
|
WLTH
2784
Wealthfront Corp
WLTH
$1.43B
| $229K | ﹤0.01% |
+24,721
| New | +$226K |
|
2785
Inogen
INGN
$157M
| $228K | ﹤0.01% |
36,793
+7,765
| +27% | +$47.9K |
|
2786
Neuropace
NPCE
$513M
| $228K | ﹤0.01% |
17,308
+2,472
| +17% | +$37.1K |
|
2787
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $227K | ﹤0.01% |
+4,803
| New | +$219K |
|
|
EU
2788
enCore Energy
EU
$268M
| $227K | ﹤0.01% |
125,913
+15,884
| +14% | +$40.6K |
|
2789
Entravision Communication
EVC
$850M
| $225K | ﹤0.01% |
75,600
+12,118
| +19% | +$37.2K |
|
2790
Stoneridge
SRI
$193M
| $225K | ﹤0.01% |
46,429
| – | – |
|
2791
ThredUp
TDUP
$412M
| $225K | ﹤0.01% |
68,427
+14,273
| +26% | +$66.2K |
|
2792
Timberland Bancorp
TSBK
$355M
| $225K | ﹤0.01% |
+5,683
| New | +$216K |
|
2793
Viemed Healthcare
VMD
$353M
| $225K | ﹤0.01% |
24,429
+5,865
| +32% | +$48.8K |
|
|
FVR
2794
FrontView REIT
FVR
$477M
| $225K | ﹤0.01% |
14,530
+2,977
| +26% | +$48K |
|
2795
Luxfer Holdings
LXFR
$457M
| $224K | ﹤0.01% |
18,328
+2,843
| +18% | +$39.6K |
|
2796
Safe Bulkers
SB
$746M
| $223K | ﹤0.01% |
35,088
+4,459
| +15% | +$26K |
|
2797
Climb Global Solutions
CLMB
$518M
| $222K | ﹤0.01% |
11,155
+2,171
| +24% | +$56.3K |
|
|
KBDC
2798
Kayne Anderson BDC
KBDC
$912M
| $222K | ﹤0.01% |
16,155
-6,911
| -30% | -$97.3K |
|
2799
STRATTEC Security
STRT
$349M
| $220K | ﹤0.01% |
+2,803
| New | +$230K |
|
|
SRTA
2800
Strata Critical Medical Inc
SRTA
$533M
| $219K | ﹤0.01% |
52,368
+11,086
| +27% | +$53.4K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.